Results 141 to 150 of about 7,047 (156)

XPO1 intensifies sorafenib resistance by stabilizing acetylation of NPM1 and enhancing epithelial-mesenchymal transition in hepatocellular carcinoma

Biomedicine and Pharmacotherapy, 2023
Nanhong Tang, Xiaoxuan Wu
exaly  

Prognostic value and therapeutic targeting of XPO1 in chronic lymphocytic leukemia

Clinical and Experimental Medicine, 2023
Qin Shuchao, Jiazhu Wu, Jinhua Liang
exaly  

Targeting XPO1-Dependent Nuclear Export in Cancer

Biochemistry (Moscow), 2022
Alexey V Sorokin, Ekaterina Kim
exaly  

Circ-XPO1 upregulates XPO1 expression by sponging multiple miRNAs to facilitate osteosarcoma cell progression

Experimental and Molecular Pathology, 2020
Lei Shen, Yang Jiang, Yongtao Li
exaly  

Prognostic and therapeutic significance of XPO1 in T-cell lymphoma

Experimental Cell Research, 2022
Danian Nie, Yiqing Li, Kezhi Huang
exaly  

Chemoproteomic Profiling of Covalent XPO1 Inhibitors to Assess Target Engagement and Selectivity

ChemBioChem, 2021
Kilian Huber, Jennifer A Ward, Jeffrey Martin   +2 more
exaly  

Induction of p53-mediated transcription and apoptosis by exportin-1 (XPO1) inhibition in mantle cell lymphoma

Cancer Science, 2014
Jo Ishizawa, Michael Andreeff, Larry Kwak   +2 more
exaly  

The nuclear export protein XPO1 — from biology to targeted therapy

Nature Reviews Clinical Oncology, 2020
Ramzi M Mohammad, Md Hafiz Uddin, Asfar S Azmi   +2 more
exaly  

Genome-wide studies in multiple myeloma identify XPO1/CRM1 as a critical target validated using the selective nuclear export inhibitor KPT-276

Leukemia, 2013
Rodger Tiedemann, Y X Zhu, M Kauffman
exaly  

DNA-Methylation-Caused Downregulation of miR-30 Contributes to the High Expression of XPO1 and the Aggressive Growth of Tumors in Pancreatic Ductal Adenocarcinoma

Cancers, 2019
Ramzi M Mohammad, Philip A Philip, Asfar S Azmi   +2 more
exaly